Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. (TSHA)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -20.01 | -11.279 | -14.947 | -10.808 |
| Net Profit Margin | - | -507.767 | - | -1,353.575 |
| Debt to Asset Ratio | 29.435 | 28.074 | 30.821 | 25.381 |
| Cash Ratio | 1,376.137 | 1,204.305 | 1,038.539 | 1,233.82 |
| Quick Ratio | 1,404.369 | 1,222.684 | 1,047.644 | 1,247.639 |
| Current Ratio | 1,404.369 | 1,222.684 | 1,047.644 | 1,247.639 |